These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 957365)

  • 1. Nature of macrophage modifications induced by the macrophage activating factor(s) (MAF): effect of enzymes and temperature.
    Dy M; Dimitriu A; Gougerot MA; Hamburger J
    J Reticuloendothel Soc; 1976 Aug; 20(2):93-102. PubMed ID: 957365
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of a cytophilic factor from challenged immune peritoneal lymphocytes in specific macrophage cytotoxicity.
    Pels E; den Otter W
    Cancer Res; 1974 Nov; 34(11):3089-94. PubMed ID: 4423930
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of H-2 antigenic sites by enzymatic treatment influences virus-specific target cell lysis.
    Ertl HC; Koszinowski UH
    J Immunol; 1976 Dec; 117(6):2112-8. PubMed ID: 993596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
    Marino PA; Adams DO
    J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte-mediated cytolysis of allogeneic tumor cells in vitro. III. Enzyme sensitivity of target cell antigens.
    Todd RF
    Cell Immunol; 1975 Dec; 20(2):257-68. PubMed ID: 1203988
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):627-36. PubMed ID: 4563478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased responsiveness to macrophage-activating factor (MAF) after alteration of macrophage membranes.
    Piessens WF; Remold HG; David JR
    J Immunol; 1977 Jun; 118(6):2078-82. PubMed ID: 325137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of tumor target binding and cytolytic activities in bone marrow culture-derived macrophages.
    Lee KC; La Posta VJ
    J Natl Cancer Inst; 1986 Dec; 77(6):1287-97. PubMed ID: 3467118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on cytophilic antibodies. IV. The effects of proteolytic enzymes (trypsin and papain) on the attachment to macrophages of cytophilic antibodies.
    Kossard S; Nelson DS
    Aust J Exp Biol Med Sci; 1968 Feb; 46(1):63-71. PubMed ID: 5650358
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The macrophage receptor for IgG: number and affinity of binding sites.
    Arend WP; Mannik M
    J Immunol; 1973 Jun; 110(6):1455-63. PubMed ID: 4712920
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism and specificity of macrophage-mediated cytotoxity.
    Gallily R; Eliahu H
    Cell Immunol; 1976 Aug; 25(2):245-55. PubMed ID: 1085202
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative studies of immunoglobulin receptors and antibody-dependent cell cytotoxicity (ADCC) in rat lymphoid organs.
    Kedar E; Ortiz de Landazuri M; Fahey JL
    J Immunol; 1974 Jan; 112(1):37-46. PubMed ID: 4130151
    [No Abstract]   [Full Text] [Related]  

  • 16. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated allograft responses in vitro. VI. Studies on macrophage-mediated cytotoxicity.
    Pfizenmaier K; Trostmann H; Röllinghoff M; Wagner H
    Immunology; 1975 Dec; 29(6):967-76. PubMed ID: 1081494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage spreading in vitro. I. Inducers of spreading.
    Rabinovitch M; DeStefano MJ
    Exp Cell Res; 1973 Mar; 77(1):323-34. PubMed ID: 4570355
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nature of the MAF-producing cell].
    Dimitriu A
    Ann Immunol (Paris); 1977; 128(1-2):151-2. PubMed ID: 848870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
    Hsu KH; Friedman H
    J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.